{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:09:33Z","timestamp":1790255373385,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      has emerged as a major nosocomial pathogen due to its remarkable ability to develop resistance to multiple antibiotics including carbapenems. The objective of this study was to assess the carbapenem resistance and detect carbapenem-resistant genes in clinical isolates of\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A cross-sectional study was conducted in Shahid Gangalal National Heart Centre, Kathmandu during February to September 2024. A total of 42\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      were isolated from different clinical specimens and identified. Antibiotic susceptibility test was performed by Kirby-Bauer disc diffusion method and carbapenemase production was assessed using modified carbapenem inactivation method and EDTA-carbapenem inactivation method. Carbapenem-resistant genes were detected through polymerase chain reaction. Among 1607 samples tested, 349 were culture positive for bacteria.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The prevalence of\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      was 12% (42\/349). Among the 42\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      isolates, 88.1% were resistant to carbapenems. Metallo-\u03b2-lactamase production was observed in 35.7% and multidrug resistance in 83.3% isolates. Resistance rates were highest against cefotaxime, cefepime and carbapenems. The\n                      <jats:italic>blaOXA-23<\/jats:italic>\n                      gene was detected in 69.1% of the isolates,\n                      <jats:italic>blaNDM-1<\/jats:italic>\n                      in 66.7%, and\n                      <jats:italic>blaVIM<\/jats:italic>\n                      in 14.3%, but none of the isolates harbored the\n                      <jats:italic>blaIMP<\/jats:italic>\n                      . Co-occurrence of\n                      <jats:italic>blaOXA-23<\/jats:italic>\n                      and\n                      <jats:italic>blaNDM-1<\/jats:italic>\n                      genes was detected in 20 (47.6%) isolates,\n                      <jats:italic>blaOXA-23<\/jats:italic>\n                      ,\n                      <jats:italic>blaNDM-1<\/jats:italic>\n                      and\n                      <jats:italic>blaVIM<\/jats:italic>\n                      in 4 (9.5%) isolates, and\n                      <jats:italic>blaNDM-1<\/jats:italic>\n                      and\n                      <jats:italic>blaVIM<\/jats:italic>\n                      in 1 (2.4%) isolate.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study showed a high burden of carbapenems resistant and multi-drug resistant\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      , likely contributed by the co-occurrence of carbapenem resistant genes. These findings provide valuable insights for clinical management and infection control of\n                      <jats:italic>A. baumannii.<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12866-025-04692-z","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:14:51Z","timestamp":1767924891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Detection of carbapenem resistance and its attributable genes in Acinetobacter baumannii isolated from cardiac patients at a referral cardiac hospital of Kathmandu"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4728-9822","authenticated-orcid":false,"given":"Prashant","family":"B K","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobita","family":"Khadka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7970-4972","authenticated-orcid":false,"given":"Upendra Thapa","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5024-6127","authenticated-orcid":false,"given":"Megha Raj","family":"Banjara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"issue":"3","key":"4692_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4103\/0974-777X.68538","volume":"2","author":"V Manchanda","year":"2010","unstructured":"Manchanda V, Sanchaita S, Singh N. Multidrug resistant Acinetobacter. J Global Infect Dis. 2010;2(3):291\u2013304.","journal-title":"J Global Infect Dis"},{"key":"4692_CR2","doi-asserted-by":"publisher","first-page":"126722","DOI":"10.1016\/j.micres.2021.126722","volume":"247","author":"HJ Mea","year":"2021","unstructured":"Mea HJ, Yong PVC, Wong EH. An overview of Acinetobacter baumannii pathogenesis: motility, adherence and biofilm formation. Microbiol Res. 2021;247:126722.","journal-title":"Microbiol Res"},{"issue":"3","key":"4692_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/antibiotics9030119","volume":"9","author":"A Moubareck","year":"2020","unstructured":"Moubareck A, Carole, Hammoudi Halat D. Insights into Acinetobacter baumannii: a review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen. Antibiotics. 2020;9(3):119.","journal-title":"Antibiotics"},{"issue":"4","key":"4692_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3390\/antibiotics9040205","volume":"9","author":"R V\u00e1zquez-L\u00f3pez","year":"2020","unstructured":"V\u00e1zquez-L\u00f3pez R, Solano-G\u00e1lvez SG, Ju\u00e1rez Vignon-Whaley JJ, et al. Acinetobacter baumannii resistance: a real challenge for clinicians. Antibiotics. 2020;9(4):205.","journal-title":"Antibiotics"},{"issue":"12","key":"4692_CR5","doi-asserted-by":"publisher","first-page":"111367","DOI":"10.1016\/j.isci.2024.111367","volume":"27","author":"A Thacharodi","year":"2024","unstructured":"Thacharodi A, Vithlani A, Hassan S, Alqahtani A, Pugazhendhi A. Carbapenem-resistant Acinetobacter baumannii raises global alarm for new antibiotic regimens. Iscience. 2024;27(12):111367.","journal-title":"Iscience"},{"issue":"3","key":"4692_CR6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/2049-632X.12125","volume":"71","author":"LC Antunes","year":"2014","unstructured":"Antunes LC, Visca P, Towner KJ. Acinetobacter baumannii: evolution of a global pathogen. Pathogens Disease. 2014;71(3):292\u2013301.","journal-title":"Pathogens Disease"},{"issue":"7","key":"4692_CR7","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1128\/AAC.01502-06","volume":"51","author":"A Bertini","year":"2007","unstructured":"Bertini A, Poirel L, Bernabeu S, et al. Multicopy  bla OXA-58 gene as a source of high-level resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51(7):2324\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Supplement2","key":"4692_CR8","doi-asserted-by":"publisher","first-page":"S166","DOI":"10.1093\/cid\/ciad109","volume":"76","author":"M Castanheira","year":"2023","unstructured":"Castanheira M, Mendes RE, Gales AC. Global epidemiology and mechanisms of resistance of Acinetobacter baumannii-calcoaceticus complex. Clin Infect Dis. 2023;76(Supplement2):S166\u201378.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"4692_CR9","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3390\/microorganisms13071501","volume":"13","author":"J de Souza","year":"2025","unstructured":"de Souza J, D\u2019Espindula HRS, Ribeiro IF, Gon\u00e7alves GA, Pillonetto M, Faoro H. Carbapenem resistance in Acinetobacter baumannii: mechanisms, therapeutics, and innovations. Microorganisms. 2025;13(7):1501.","journal-title":"Microorganisms"},{"issue":"2","key":"4692_CR10","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1128\/AAC.00622-11","volume":"56","author":"Y-T Lee","year":"2012","unstructured":"Lee Y-T, Kuo S-C, Chiang M-C, et al. Emergence of carbapenem-resistant non-baumannii species of Acinetobacter harboring a  bla OXA-51-like gene that is intrinsic to A. baumannii. Antimicrob Agents Chemother. 2012;56(2):1124\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"4692_CR11","first-page":"DC38","volume":"8","author":"A Khajuria","year":"2014","unstructured":"Khajuria A, Praharaj AK, Kumar M, Grover N. Molecular characterization of carbapenem resistant isolates of Acinetobacter baumannii in an intensive care unit of a tertiary care centre at central India. J Clin Diagn Res. 2014;8(5):DC38.","journal-title":"J Clin Diagn Res"},{"issue":"5\u20136","key":"4692_CR12","first-page":"31","volume":"4","author":"V Karbasizade","year":"2015","unstructured":"Karbasizade V, Heidari L, Jafari R. Detection of oxa-type carbapenemase genes in Acinetobacter baumannii isolates from nosocomial infections in Isfahan hospitals, Iran. J Med Bacteriol. 2015;4(5\u20136):31\u20136.","journal-title":"J Med Bacteriol"},{"key":"4692_CR13","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3389\/fmicb.2016.01126","volume":"7","author":"S Chatterjee","year":"2016","unstructured":"Chatterjee S, Datta S, Roy S, et al. Carbapenem resistance in Acinetobacter baumannii and other Acinetobacter spp. causing neonatal sepsis: focus on NDM-1 and its linkage to IS Aba125. Front Microbiol. 2016;7:1126.","journal-title":"Front Microbiol"},{"issue":"1","key":"4692_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2174\/1874285801913010239","volume":"13","author":"KP Acharya","year":"2019","unstructured":"Acharya KP, Phuyal S, Koirala N. Prevent misuse of antibiotics in Nepal. Open Microbiol J. 2019;13(1):239\u201340.","journal-title":"Open Microbiol J"},{"key":"4692_CR15","unstructured":"Versalovic J, editor. Manual of Clinical Microbiology, Tenth edition. John Wiley and Sons Inc;\u00a02011."},{"issue":"6","key":"4692_CR16","doi-asserted-by":"publisher","first-page":"107358","DOI":"10.1016\/j.ijantimicag.2024.107358","volume":"64","author":"PK Chen","year":"2024","unstructured":"Chen PK, Liu C-Y, Kuo H-Y, et al. Emergence of extensively-drug-resistant hypervirulent Acinetobacter baumannii isolated from patients with bacteraemia: bacterial phenotype and virulence analysis. Int J Antimicrob Agents. 2024;64(6):107358.","journal-title":"Int J Antimicrob Agents"},{"key":"4692_CR17","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. CLSI supplement M100, 34th edition. CLSI M100. 34 ed. Wayne, PA: Clinical and Laboratory Standards Institute, 2024."},{"issue":"3","key":"4692_CR18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381.","journal-title":"Clin Microbiol Infect"},{"key":"4692_CR19","doi-asserted-by":"publisher","unstructured":"Pranita D, Tamma, Simner PJ. Phenotypic detection of carbapenemase-producing organisms from clinical isolates. J Clin Microbiol. 2018;56(11):10. https:\/\/doi.org\/10.1128\/jcm.01140-01118.","DOI":"10.1128\/jcm.01140-01118"},{"key":"4692_CR20","doi-asserted-by":"crossref","unstructured":"Verma G, Singh N, Smriti S et al. Modified carbapenem inactivation method and ethylenediaminetetraacetic acid (EDTA)-carbapenem inactivation method for detection of carbapenemase-producing Enterobacterales and Pseudomonas aeruginosa. Cureus. 2024;16(6):e63340.","DOI":"10.7759\/cureus.63340"},{"issue":"10","key":"4692_CR21","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1128\/JCM.40.10.3798-3801.2002","volume":"40","author":"D Yong","year":"2002","unstructured":"Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem-EDTA disk method for differentiation of metallo-\u03b2-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 2002;40(10):3798\u2013801.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"4692_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ijantimicag.2006.01.004","volume":"27","author":"N Woodford","year":"2006","unstructured":"Woodford N, Ellington MJ, Coelho JM, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006;27(4):351\u20133.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"4692_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","volume":"70","author":"L Poirel","year":"2011","unstructured":"Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119\u201323.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2003","key":"4692_CR24","first-page":"2013","volume":"2023","author":"S Bista","year":"2023","unstructured":"Bista S, Yadav B, Syangtan G, et al. Emergence of IS Aba1-linked oxacillinase genes among carbapenem resistant acinetobacter baumannii isolates in a tertiary cardiac center, Nepal. BioRxiv. 2023;2023(2003):2013\u2013532405.","journal-title":"BioRxiv"},{"key":"4692_CR25","doi-asserted-by":"crossref","unstructured":"Raut S, Rijal KR, Khatiwada S et al. Trend and characteristics of Acinetobacter baumannii infections in patients attending Universal College of Medical Sciences, Bhairahawa, Western Nepal: a longitudinal study of 2018. Infect Drug Resist. 2020;13:1631\u201341.","DOI":"10.2147\/IDR.S257851"},{"issue":"1","key":"4692_CR26","doi-asserted-by":"publisher","first-page":"8842625","DOI":"10.1155\/2024\/8842625","volume":"2024","author":"A Gurung","year":"2024","unstructured":"Gurung A, Napit R, Shrestha B, Lekhak B. Carbapenem resistance in Acinetobacter calcoaceticus-baumannii complex isolates from Kathmandu model Hospital, Nepal, is attributed to the presence of blaOXA-23-like and blaNDM-1 genes. Biomed Res Int. 2024;2024(1):8842625.","journal-title":"Biomed Res Int"},{"issue":"4","key":"4692_CR27","doi-asserted-by":"publisher","first-page":"899","DOI":"10.33314\/jnhrc.v20i4.4257","volume":"20","author":"L Neupane","year":"2023","unstructured":"Neupane L, Sah AK, Rayamajhee B, Pokhrel A, Singh A. Detection of bla OXA -23 gene from carbapenem-resistant Acinetobacter baumannii. J Nepal Health Res Counc. 2023;20(4):899\u2013905.","journal-title":"J Nepal Health Res Counc"},{"key":"4692_CR28","doi-asserted-by":"publisher","first-page":"725","DOI":"10.2147\/IDR.S239514","volume":"13","author":"SK Yadav","year":"2020","unstructured":"Yadav SK, Bhujel R, Hamal P, Mishra SK, Sharma S, Sherchand JB. Burden of multidrug-resistant Acinetobacter baumannii infection in hospitalized patients in a tertiary care hospital of Nepal. Infect Drug Resist. 2020;13:725\u201332.","journal-title":"Infect Drug Resist"},{"issue":"3","key":"4692_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.4161\/viru.19700","volume":"3","author":"A Howard","year":"2012","unstructured":"Howard A, O\u2019Donoghue M, Feeney A, Sleator RD. Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence. 2012;3(3):243\u201350.","journal-title":"Virulence"},{"key":"4692_CR30","doi-asserted-by":"crossref","unstructured":"Munoz-Price, Silvia L, Weinstein RA. Acinetobacter infection. New England Journal of Medicine. 2008;358(12):1271\u20131281.","DOI":"10.1056\/NEJMra070741"},{"key":"4692_CR31","doi-asserted-by":"crossref","unstructured":"Huang L, Tang J, Tian G, Tao H, Li Z. Risk factors, outcomes, and predictions of extensively drug-resistant Acinetobacter baumannii nosocomial infections in patients with nervous system diseases. Infect Drug Resist. 2023;16:7327\u201337.","DOI":"10.2147\/IDR.S439241"},{"issue":"8","key":"4692_CR32","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3390\/antibiotics11081086","volume":"11","author":"D Alrahmany","year":"2022","unstructured":"Alrahmany D, Omar AF, Alreesi A, Harb G, Ghazi IM. Acinetobacter baumannii infection-related mortality in hospitalized patients: risk factors and potential targets for clinical and antimicrobial stewardship interventions. Antibiotics. 2022;11(8):1086.","journal-title":"Antibiotics"},{"issue":"3","key":"4692_CR33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3201\/eid1803.111330","volume":"18","author":"L Poirel","year":"2012","unstructured":"Poirel L, Ber\u00e7ot B, Millemann Y, Bonnin RA, Pannaux G, Nordmann P. Carbapenemase-producing Acinetobacter spp. In cattle, France. Emerg Infect Dis. 2012;18(3):523.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"4692_CR34","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4103\/ijmr.IJMR_2085_17","volume":"149","author":"S Vijayakumar","year":"2019","unstructured":"Vijayakumar S, Mathur P, Kapil A, et al. Molecular characterization & epidemiology of carbapenem-resistant Acinetobacter baumannii collected across India. Indian J Med Res. 2019;149(2):240\u20136.","journal-title":"Indian J Med Res"},{"key":"4692_CR35","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jgar.2024.07.017","volume":"38","author":"M Sakuma","year":"2024","unstructured":"Sakuma M, Tohya M, Hishinuma T, Sherchand JB, Kirikae T, Tada T. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates from a hospital in Nepal. J Global Antimicrob Resist. 2024;38:363\u20137.","journal-title":"J Global Antimicrob Resist"},{"issue":"9","key":"4692_CR36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","volume":"10","author":"KK Kumarasamy","year":"2010","unstructured":"Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10(9):597\u2013602.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"4692_CR37","first-page":"8861204","volume":"2020","author":"S Gautam","year":"2020","unstructured":"Gautam S, Bhattarai N, Rai K, Poudyal A, Khanal B. Detection of  bla NDM-1 encoding imepenemase among the imipenem\u2010resistant Gram\u2010negative bacilli isolated from various clinical samples at a tertiary care hospital of Eastern Nepal: a descriptive cross\u2010sectional study. Int J Microbiol. 2020;2020(1):8861204.","journal-title":"Int J Microbiol"},{"key":"4692_CR38","doi-asserted-by":"publisher","first-page":"1068840","DOI":"10.3389\/fcimb.2022.1068840","volume":"12","author":"S Sharma","year":"2023","unstructured":"Sharma S, Banerjee T, Yadav G, Kumar A. Susceptibility profile of blaOXA-23 and metallo-\u03b2-lactamases co-harbouring isolates of carbapenem resistant Acinetobacter baumannii (CRAB) against standard drugs and combinations. Front Cell Infect Microbiol. 2023;12:1068840.","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"4692_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.drup.2012.06.001","volume":"15","author":"N Karah","year":"2012","unstructured":"Karah N, Sundsfjord A, Towner K, Samuelsen \u00d8. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist Updates. 2012;15(4):237\u201347.","journal-title":"Drug Resist Updates"},{"issue":"10","key":"4692_CR40","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1093\/jac\/dkq273","volume":"65","author":"K Karthikeyan","year":"2010","unstructured":"Karthikeyan K, Thirunarayan M, Krishnan P. Coexistence of blaOXA-23 with bla NDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J Antimicrob Chemother. 2010;65(10):2253\u20134.","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"4692_CR41","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1097\/CM9.0000000000000193","volume":"132","author":"Z-Y Huang","year":"2019","unstructured":"Huang Z-Y, Li J, Shui J, Wang H-C, Hu Y-M, Zou M-X. Co-existence of blaOXA-23 and blaVIM in carbapenem-resistant Acinetobacter baumannii isolates belonging to global complex 2 in a Chinese teaching hospital. Chin Med J. 2019;132(10):1166\u201372.","journal-title":"Chin Med J"},{"key":"4692_CR42","unstructured":"Santimaleeworagun W, Samret W, Preechachuawong P, Kerdsin A, Jitwasinkul T. Emergence of co-carbapenemase genes, bla (OXA -23), bla (VIM) and bla (NDM) in carbapenem resistant Acinetobacter baumannii clinical isolates. Southeast Asian J Trop Med Public Health. 2016;47:1001\u20137."},{"key":"4692_CR43","doi-asserted-by":"crossref","unstructured":"Ejaz H, Ahmad M, Younas S, et al. Molecular epidemiology of extensively-drug resistant Acinetobacter baumannii sequence type 2 co-harboring  blaNDM and  blaOXA from clinical origin. Infect Drug Resist. 2021;14:1931\u20139.","DOI":"10.2147\/IDR.S310478"},{"key":"4692_CR44","doi-asserted-by":"crossref","unstructured":"Nasrabadi KS, Ahmadi Y, Ghasemi SM, Shokri D. Identification of bla OXA\u2009\u2013\u200951-23-58, bla VIM, bla NDM, and bla IMP carbapenemase genes in Acinetobacter baumannii isolates from hospitalized patients. BMC Research Notes. 2024;17(1):392.","DOI":"10.1186\/s13104-024-07047-5"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04692-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04692-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04692-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T10:23:08Z","timestamp":1771323788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-025-04692-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4692"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04692-z","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the study was obtained from the Institutional Review Committee (IRC) of Shahid Gangalal National Heart Centre (SGNHC) Hospital (Ref. No.: 4-2024). Written consent was taken from each patient for voluntarily participation before collecting data and samples. Declaration of Helsinki and guidelines of Nepal Health Research Council were adhered throughout the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}